Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor

Background: After an initial response to EGFR targeted therapy, secondary resistance almost invariably ensues, thereby limiting the clinical benefit of the drug. Hence, it has been recognized that the successful implementation of targeted therapy in the treatment of HNSCC cancer is very much depende...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Main Authors: Boeckx, Carolien, Blockx, Lina, de Beeck, Ken Op, Limame, Ridha, Camp, Guy Van, Peeters, Marc, Vermorken, Jan B, Specenier, Pol, Wouters, An, Baay, Marc, Lardon, Filip
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2015
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4529614/
https://ncbi.nlm.nih.gov/pubmed/26269754
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares